Depression as a Comorbidity to Diabetes: Implications for Management

Journal for Nurse Practitioners

Volumn 5, Issue 7, 2009, Pages 523-535

  Riley, Andrea A ^a   McEntee, Mindy L ^a   Gerson, Linda ^a   Dennison, Cheryl R ^a  

^a NONE

Author keywords

depression; diabetes; management; primary care; screening

Indexed keywords

EID: 67649556461     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2009.03.020     Document Type: Article

References (142)

1. Anderson R.J., Freedland K.E., Clouse R.E., and Lustman P.J. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24 (2001) 1069-1078
2. Lustman P.J., and Clouse R.E. Section III: practical considerations in the management of depression in diabetes. Diabetes Spectr 17 (2004) 160-166
3. Lustman P.J., Griffith L.S., Freedland K.E., and Clouse R.E. The course of major depression in diabetes. Gen Hosp Psychiatry 19 (1997) 138-143
4. DiMatteo M.R., Lepper H.S., and Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160 (2000) 2101-2107
5. Katon W., and Sullivan M.D. Depression and chronic medical illness. J Clin Psychiatry 51 (1990) 3-11
6. Ford D.E. Optimizing outcomes for patients with depression and chronic medical illnesses. Am J Med 121 (2008) S38-S44
7. Ciechanowski P.S., Katon W.J., and Russo J.E. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 160 (2000) 3278-3285
8. Ciechanowski P.S., Katon W.J., Russo J.E., and Hirsch I.B. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 25 (2003) 246-252
9. McKellar J.D., Humphreys K., and Piette J.D. Depression increases diabetes symptoms by complicating patients' self-care adherence. Diabetes Educ 30 (2004) 485-492
10. Park H., Hong Y., Lee H., Ha E., and Sung Y. Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. J Clin Epidemiol 57 (2004) 978-984
11. Lin E., Katon W., Von Korff M., et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 27 (2004) 2154-2160
12. Anderson D., Horton C., O'Toole M.L., et al. Integrating depression care with diabetes care in real-world settings: lessons from the Robert Wood Johnson Foundation Diabetes Initiative. Diabetes Spectr 20 1 (2007) 10-16
13. Gonzalez J.S., Safren S.A., Cagliero E., et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 30 (2007) 2222-2227
14. Lin E.H., Simon G.E., Katzelnick D.J., and Pearson S.D. Does physician education on depression management improve treatment in primary care?. J Gen Intern Med 16 (2001) 614-619
15. Kilbourne A.M., Reynolds C.F., Good C.B., et al. How does depression influence diabetes medication adherence in older patients?. Am J Geriatr Psychiatry 13 (2005) 202-210
16. Ludman E.J., Katon W., Russo J., et al. Depression and diabetes symptom burden. Gen Hosp Psychiatry 26 6 (2004) 430-436
17. Lustman P.J., Anderson R.J., Freedland K.E., et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23 (2000) 934-942
18. De Groot M., Anderson R., Freedland K.E., Clouse R.E., and Lustman P.J. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63 (2001) 619-630
19. Rush W.A., Whitebird R.R., Rush M.R., Solberg L.I., and O'Connor P.J. Depression in patients with diabetes: does it impact clinical goals?. J Am Board Fam Med 21 5 (2008) 392-397
20. Clouse R.E., Lustman P.J., Freedland K.E., et al. Depression and coronary heart disease in women with diabetes. Psychosom Med 65 (2003) 376-383
21. Katon W., Von Korff M., Ciechanowski P., et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27 (2004) 914-920
22. Zhang X., Norris S.L., Gregg E.W., et al. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 161 (2005) 652-660
23. Katon W.J., Rutter C., Simon G., et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28 (2005) 2668-2672
24. Egede L.E., Nietert P.J., and Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 28 (2005) 1339-1345
25. Egede L.E. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 27 (2004) 421-428
26. Egede L.E., Zheng D., and Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25 (2002) 464-470
27. Goldney R.D., Phillips P.J., Fisher L.J., and Wilson D.H. Diabetes, depression, and quality of life. Diabetes Care 27 (2004) 1066-1070
28. Finkelstein E.A., Bray J.W., Chen H., et al. Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 26 (2003) 415-420
29. Williams Jr. J.W., Katon W., Lin E., et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 140 (2004) 1015-1024
30. Lustman P.J., and Clouse R.E. Identifying depression in adults with diabetes. Clin Diabetes 15 (1997) 78-81
31. Egede L.E., and Simpson K. Epidemiology, treatment and costs of depression in adults with type 2 diabetes. Expert Rev Pharmacoeconomics Outcome Res 3 (2003) 251-262
32. Katon W.J., Simon G., Russo J., et al. Quality of depression care in a population-based sample of patients with diabetes and depression. Med Care 42 (2004) 1222-1229
33. Eaton W.W. Epidemiologic evidence on the comorbidity of depression and diabetes. J Psychosom Res 53 (2002) 903-906
34. Talbot F., and Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link?. Diabetes Care 23 (2000) 1556-1562
35. Connell C.M., Davis W.K., Gallant M.P., and Sharpe P.A. Impact of social support, social cognitive variables, and perceived threat on depression among adults with diabetes. Health Psychol 13 (1994) 263-273
36. Talbot F., Nouwen A., Gingras J., Belanger A., and Audet J. Relations of diabetes intrusiveness and personal control to symptoms of depression among adults with diabetes. Health Psychol 18 (1999) 537-542
37. Bailey B.J. Mediators of depression in adults with diabetes. Clin Nurs Res 5 (1996) 28-42
38. De Groot M., Auslander W., Williams J.H., Sherranden M., and Haire-Joshu D. Depression and poverty among African American women at risk for type 2 diabetes. Ann Behav Med 25 (2003) 172-181
39. Macrodimitris S.D., and Endler N.S. Coping, control, and adjustment in type 2 diabetes. Health Psychol 20 (2001) 208-216
40. Egede L.E., and Zheng D. Independent factors associated with major depressive disorder in a national sample. Diabetes Care 26 (2003) 104-111
41. Li C., Ford E.S., Strine T.W., and Mokdad A.H. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 Behavioral Risk Factor Surveillance System. Diabetes Care 31 (2008) 105-107
42. Peyrot M., and Rubin R.R. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 20 (1997) 585-590
43. Bell R.A., Smith S.L., Arcury T.A., et al. Prevalence and correlates of depressive symptoms among rural older African Americans, Native Americans, and whites with diabetes. Diabetes Care 28 (2005) 823-829
44. Golden S.H., Lazo M., Carnethon M., et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 299 23 (2008) 2751-2759
45. Everson S.A., Maty S.C., Lynch J.W., and Kaplan G.A. Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J Psychosom Res 53 (2002) 891-895
46. Kessler R.C., Berglund P., Demler O., et al. National Comorbidity Survey Replication: the epidemiology of major depressive disorder: results from the National Comorbidity Replication (NCS-R). JAMA 289 (2003) 3095-3105
47. Fisher L., Chesla C.A., Mullan J.T., Skaff M.M., and Kanter R.A. Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care 24 (2001) 1751-1757
48. Jacobson A.M., Samson J.A., Weinger K., and Ryan C.M. Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression?. Int Rev Neurobiol 51 (2002) 455-479
49. Rubin R.R., and Peyrot M.F. Quality of life and diabetes. Diabetes Metab Res Rev 15 (1999) 205-218
50. Rajala U., Keinänen-Kiukaanniemi S., and Kivelä S.-L. Non-insulin-dependent diabetes mellitus and depression in a middle-aged Finnish population. Soc Psychiatry Psychiatr Epidemiol 32 (1997) 363-367
51. De Groot M., Jacobson A.M., Samson J.A., and Welch G. Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res 46 (1999) 425-435
52. van Tilburg M., McCaskill C.C., Lane J.D., et al. Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med 63 (2001) 551-555
53. Lustman P.J., Freedland K.E., Griffith L.S., and Clouse R.E. Predicting response to cognitive behavior therapy of depression in type 2 diabetes. Gen Hosp Psychiatry 20 (1998) 302-306
54. Lustman P.J., Griffith L.S., Clouse R.E., and Cryer P.E. Psychiatric illness in diabetes mellitus: relation to symptoms and glucose control. J Nerv Mental Dis 174 (1986) 736-746
55. Katon W.J. The comorbidity of diabetes mellitus and depression. Am J Med 121 (2008) S8-S15
56. Yoshida S., Hirai M., Suzuki S., Awata S., and Oka Y. Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes. Psychiatry Clin Neurosci 63 (2009) 65-72
57. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 62 (2007) 31-38
58. Lustman P.J., Griffith L.S., and Clouse R.E. Depression in adults with diabetes: results of 5-yr follow-up study. Diabetes Care 11 (1988) 605-612
59. Cameron O.G., Kronfol Z., Greden J.F., and Carroll B.J. Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatry 41 (1984) 1090-1095
60. Björntorp P., Holm G., and Rosmond R. Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med 16 (1999) 373-383
61. Rosmond R., and Björntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 247 (2001) 188-197
62. Brown E.S., Varghese F.P., and McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biol Psychiatry 55 (2004) 1-9
63. Schmidt M.I., Duncan B.B., Sharrett A.R., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Artherosclerosis Risk in Communities Study): a cohort study. Lancet 353 (1999) 1649-1652
64. Dandona P., Aljada A., and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25 (2004) 4-7
65. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., and Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
66. Han T.S., Sattar N., Williams K., Gonzalez-Villalpando C., et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25 (2002) 2016-2021
67. Knol M.J., Twisk J.W.R., Beekman A., et al. Depression as a risk factor for the onset of type 2 diabetes melitus: a meta-analysis. Diabetologia 49 (2006) 837-845
68. Musselman D.L., Betan E., Larson H., and Phillips L.S. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54 (2003) 317-329
69. Williams M.M., Clouse R.E., and Lustman P.J. Treating depression to prevent diabetes and its complications: understanding depression as a medical risk factor. Clin Diabetes 24 (2006) 79-86
70. Eaton W.E., Armenian H., Gallo J., Pratt L., and Ford D.E. Depression and risk of onset of type II diabetes: a prospective population-based study. Diabetes Care 19 (1996) 1097-1102
71. Kawakami N., Takatsuka N., Shimizu H., and Ishibashi H. Depressive symptoms and the occurrence of type 2 diabetes among Japanese men. Diabetes Care 22 (1999) 1071-1076
72. Arroyo C., Hu F.B., Ryan L.M., et al. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 27 (2004) 129-133
73. Carnethon M.R., Biggs M.L., Barzilay J.I., et al. Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults. Arch Intern Med 167 (2007) 802-807
74. van den Akker M., Schuurman A., Metsemakers J., and Buntinx F. Is depression related to subsequent diabetes mellitus?. Acta Psychiatr Scand 110 (2004) 178-183
75. Palinkas L.A., Lee P.P., and Barrett-Connor E. A prospective study of type 2 diabetes and depressive symptoms in the elderly: the Rnacho Bernardo Study. Diabet Med 21 (2004) 1185-1191
76. Brown L.C., Majumdar S.R., Newman S.C., and Johnson J.A. Type 2 diabetes does not increase risk of depression. Can Med Assoc J 175 (2006) 42-46
77. Brown L.C., Majumdar S.R., and Johnson J.A. Type of antidepressant therapy and risk of type 2 diabetes in people with depression. Diabetes Res Clin Pract 79 (2008) 61-67
78. Chida Y., and Hamer M. An association of adverse psychological factors with diabetes mellitus: a meta-analytic review of longitudinal cohort studies. Diabetologia 51 (2008) 2168-2178
79. Knol M.J., Heerdink E.R., Egberts A., et al. Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med 69 (2007) 300-305
80. Lustman P.J., Freedland K.E., Carney R.M., Hong B.A., and Clouse R.E. Similarity of depression in diabetic and psychiatric patients. Psychosom Med 54 (1992) 602-611
81. Simon G.E., and Von Korff M. Medical co-morbidity and validity of DSM-IV depression criteria. Psychol Med 35 (2005) 1-10
82. Yates W.R., Mitchell J., Rush A.J., et al. Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. Gen Hosp Psychiatry 26 6 (2004) 421-429
83. Peterson T., Iosifescu D.V., Papakostas G.I., Shear D.L., and Fava M. Clinical characteristics of depressed patients with comorbid diabetes mellitus. Int Clin Psychopharmacol 21 (2006) 43-47
84. Hermanns N., Kulzer B., Krichbaum M., Kubiak T., and Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 49 (2006) 469-477
85. Lustman P.J., Griffith L.S., and Clouse R.E. Depression in adults with diabetes. Semin Clin Neuropsychiatry 2 (1997) 15-23
86. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 31 (2008) S12-S54
87. U.S. Preventive Services Task Force (USPSTF). Screening for depression: recommendations and rationale. Ann Intern Med 136 (2002) 760-764
88. Kroenke K., Taylor-Vaisey A., Dietrich A.J., and Oxman T.E. Interventions to improve provider diagnosis and treatment of mental disorders in primary care. A critical review of the literature. Psychosomatics 41 (2000) 39-52
89. Rubin R.R., Ciechanowski P., Egede L.E., Lin E., and Lustman P. Recognizing and treating depression in patients with diabetes. Curr Diabetes Rep 4 (2004) 119-125
90. Katon W., Von Korff M., Lin E., Bush T., and Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care 30 (1992) 67-76
91. Nau D.P., Chao J., and Aikens J.E. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications. Res Social Adm Pharm 1 (2005) 378-388
92. Lustman P.J., Griffith L.S., Clouse R.E., et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59 (1997) 241-250
93. Lustman P.J., Freedland K.E., Griffith L.S., and Clouse R.E. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23 (2000) 618-623
94. Lustman P.J., and Clouse R.E. Treatment of depression in diabetes: impact on mood and medical outcome. J Psychosom Res 53 (2002) 917-924
95. Lustman P.J., Clouse R.E., Nix B.D., et al. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 63 (2006) 521-529
96. Lustman P.J., Williams M.M., Sayuk G.S., Nix B.D., and Clouse R.E. Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care 30 (2007) 459-466
97. Goodnick P.J., Henry J.H., and Buki V.M. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 56 (1995) 128-136
98. Goodnick P.J., Kumar A., Henry J.H., Buki V.M.V., and Goldberg R.B. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull 33 (1997) 261-264
99. Goodnick P.J. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 13 (2001) 31-41
100. Gülseren L., Gülseren S., Hekimsoy Z., and Mete L. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients. Arch Med Res 36 (2005) 159-165
101. Paile-Hyvärinen M., Wahlbeck K., and Eriksson J.G. Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial. BMC Fam Pract 8 (2007) 34
102. Lustman P.J., Griffith L.S., Freedland K.E., Kissel S.S., and Clouse R.E. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 129 (1998) 613-621
103. Georgiades A., Zucker N., Friedman K.E., et al. Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med 69 (2007) 235-241
104. van der Ven N.C., Hogenelst M.H., Tromp-Wever A.M., et al. Short-term effects of cognitive behavioural group training (CBGT) in adult type 1 diabetes patients in prolonged poor glycaemic control. A randomized controlled trial. Diabetic Med 22 (2005) 1619-1623
105. Snoek F.J., van der Ven N.C.W., Twisk J.W.R., et al. Cognitive behavioural therapy (CBT) compared with blood glucose awareness trainign (BGAT) in poorly controlled type 1 diabetic patients: long-term effects on HbA1c moderated by depression. A randomized controlled trial. Diabetic Med 25 (2008) 1337-1342
106. Ismail K., Winkley K., and Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 363 (2004) 1589-1597
107. Katon W.J., Von Korff M., Lin E., et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 61 (2004) 1042-1049
108. De Groot M., Pinkerman B., Wagner J., and Hockman E. Depression treatment and satisfaction in a multicultural sample of type 1 and type 2 diabetic patients. Diabetes Care 29 (2006) 549-553
109. Keller M.B., McCullough J.P., Klein D.N., et al. A comparison of nefazodone, the cognitive-behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New Engl J Med 342 (2000) 1462-1470
110. Lustman P.J., and Anderson R. Depression in adults with diabetes. Pychiatric Times 19 1 (2002). http://www.psychiatrictimes.com/display/article/10168/47911
111. Roose S.P., and Spatz E. Treating depression in patients with ischaemic heart disease: which agents are best to use and to avoid?. Drug Safety 20 (1999) 459-465
112. Clark M. Identification and treatment of depression in people with diabetes. Diabetes Primary Care 5 (2003) 124-127
113. Mason J., Freemantle N., and Eccles M. Fatal toxicity associated with antidepressant use in primary care. Br J Gen Pract 50 (2000) 366-370
114. Zimmermann U., Kraus T., Himmerlich H., Schuld A., and Pollmächer T. Epidemiology, implications, and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 37 (2003) 193-220
115. Max M.B., Lynch S.A., Muir J., et al. Effects of desipramine, amitriptyline, and fluoxetine in diabetic neuropathy. New Engl J Med 326 (1992) 1250-1256
116. Ghaeli P., Shahsavand E., Mesbahi M., et al. Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder. J Clin Psychopharmacol 24 (2004) 386-388
117. Rambelomanana S., Depont F., Forest D., et al. Antidepressants: general practitioners' opinions and clinical practice. Acta Psychiatr Scand 113 (2006) 460-467
118. Stafford R.S., Ausiello J.C., Misra B., and Saglam D. National patterns of depression treatment in primary care. Prim Care Companion J Clin Psychiatry 2 (2000) 211-216
119. Williams M.M., Clouse R.E., Nix B.D., et al. Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes. Diabetes Care 30 (2007) 801-806
120. Paile-Hyvärinen M., Wahlbeck K., and Eriksson J.G. Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial. BMC Fam Pract 4 (2003) 7-12
121. Norris S.L., Zhang X., Avenell A., et al. Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 164 (2004) 1395-1404
122. Sindrup S.H., Gram L.F., Brøsen K., Eshøj O., and Mogensen E.F. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42 (1990) 135-144
123. Sindrup S.H., Bjerre U., Dejgaard A., et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 52 (1992) 547-552
124. Sindrup S.H., and Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83 (1999) 389-400
125. Goodnick P.J., Jimenz I., and Kumar A. Sertraline in diabetic neuropathy: preliminary results. Ann Clin Psychiatry 9 (1997) 255-257
126. Duby J.J., Campbell R.K., Setter S.M., White J.R., and Rasmussen K.A. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 61 (2004) 160-173
127. Raskin J., Pritchett Y.L., Wang F., et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 6 (2005) 346-356
128. Raskin J., Smith T.R., Wong K., et al. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliat Med 9 (2006) 29-40
129. Hardy T., Sachson R., Shen S., Armbruster M., and Boulton A. Does treatment with duloxetine for neuropathic pain impact glycemic control?. Diabetes Care 30 (2007) 21-26
130. Rowbotham M.C., Goli V., Kunz N.R., and Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110 (2004) 697-706
131. Stahl S.M., Grady M.M., Moret C., and Briley M. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10 (2005) 732-747
132. McKeage K. Treatment options for the management of diabetic painful neuropathy: best current evidence. Curr Opin Neurol 20 (2007) 553-557
133. Rowland D.L., Myers L., Culver A., and Davidson J.M. Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction. J Clin Psychopharmacol 17 (1997) 350-357
134. Semenchuk M.R., Sherman S., and Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 57 (2001) 1583-1588
135. Hilty D.M., McCarron R.M., and Ton H. Management of mental illness in patients with diabetes. Prim Care Clin Office Pract 34 (2007) 713-730
136. Fawcett J., and Barkin R.L. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord 51 (1998) 267-285
137. Himmerich H., Fulda S., Schaaf L., et al. Changes in weight and glucose tolerance during treatment with mirtazapine. Diabetes Care 29 (2006) 170-171
138. Weber-Hamann B., Gilles M., Schilling C., et al. Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine. J Clin Psychopharmacol 28 (2008) 581-584
139. Arnold P., Vuadens P., Kuntzer T., Gobelet C., and Deriaz O. Mirtazapine decreases the pain feeling in healthy participants. Clin J Pain 24 (2008) 116-119
140. Freynhagen R., Muth-Selbach U., Lipfert P., et al. The effect of mirtazapine in patients with chronic pain and concomitant depression. Curr Med Res Opin 22 (2006) 257-264
141. Winkley K., Landau S., Eisler I., and Ismail K. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ 333 (2006) 65-68
142. Wagner J., Tsimikas J., Abbott G., De Groot M., and Heapy A. Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment. Diabetes Res Clin Pract 75 (2007) 119-122